Stock listing
NASDAQ:HYPR Hyperfine, Inc. Stock
Home listing (NASDAQ) of Hyperfine, Inc.
Follow Hyperfine, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:HYPR
$0.547 USD +0.002 (+0.3%)
Close on Nov 20, 2026
- Day range
- $0.488 – $0.550 USDNov 20, 2026
- Volume
- 1.24M sharesNov 20, 2026
- Market cap
- $49.73M USDAt the close on Nov 20, 2026 · price × 90.99M shares outstanding
- 52-week range
- $0.488 – $1.935 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $617,612 USDMedian day 524,500 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:HYPR · Home | $0.547 USD | +0.002 (+0.3%) | 1,239,541 | $0.530 | $0.550 | $0.488 | $0.545 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:HYPR · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.547 | +0.002 | +0.3% | $0.530 | $0.550 | $0.488 | 1,239,541 | |
| $0.545 | -0.017 | -3.0% | $0.562 | $0.600 | $0.531 | 940,869 | |
| $0.562 | -0.048 | -7.9% | $0.600 | $0.605 | $0.543 | 1,163,000 | |
| $0.610 | -0.019 | -3.1% | $0.625 | $0.636 | $0.604 | 497,698 | |
| $0.629 | -0.050 | -7.4% | $0.671 | $0.680 | $0.611 | 772,630 | |
| $0.679 | -0.032 | -4.5% | $0.690 | $0.699 | $0.670 | 497,988 | |
| $0.711 | +0.030 | +4.4% | $0.700 | $0.719 | $0.684 | 377,463 | |
| $0.681 | -0.026 | -3.6% | $0.740 | $0.745 | $0.674 | 409,883 | |
| $0.707 | -0.013 | -1.8% | $0.724 | $0.743 | $0.691 | 416,280 | |
| $0.720 | +0.034 | +5.0% | $0.700 | $0.741 | $0.680 | 496,400 | |
| $0.685 | -0.065 | -8.6% | $0.751 | $0.755 | $0.670 | 826,769 | |
| $0.750 | +0.058 | +8.4% | $0.690 | $0.759 | $0.682 | 555,572 | |
| $0.692 | -0.032 | -4.5% | $0.724 | $0.724 | $0.667 | 1,309,137 | |
| $0.725 | +0.007 | +1.0% | $0.724 | $0.740 | $0.710 | 198,424 | |
| $0.718 | -0.026 | -3.5% | $0.730 | $0.752 | $0.710 | 564,764 | |
| $0.744 | -0.041 | -5.2% | $0.780 | $0.780 | $0.735 | 679,274 | |
| $0.785 | +0.035 | +4.7% | $0.747 | $0.785 | $0.722 | 937,531 | |
| $0.750 | +0.027 | +3.7% | $0.746 | $0.760 | $0.720 | 472,772 | |
| $0.723 | -0.001 | -0.2% | $0.724 | $0.740 | $0.713 | 237,961 | |
| $0.724 | -0.001 | -0.2% | $0.711 | $0.729 | $0.696 | 428,006 | |
| $0.726 | -0.020 | -2.7% | $0.731 | $0.751 | $0.705 | 504,804 | |
| $0.746 | -0.028 | -3.6% | $0.773 | $0.780 | $0.722 | 501,332 | |
| $0.774 | -0.003 | -0.4% | $0.760 | $0.777 | $0.750 | 274,243 | |
| $0.777 | +0.022 | +2.9% | $0.760 | $0.781 | $0.740 | 342,888 | |
| $0.755 | -0.025 | -3.2% | $0.790 | $0.790 | $0.741 | 559,300 | |
| $0.780 | -0.020 | -2.5% | $0.800 | $0.812 | $0.761 | 949,800 | |
| $0.800 | -0.052 | -6.1% | $0.850 | $0.855 | $0.800 | 777,300 | |
| $0.852 | -0.054 | -6.0% | $0.890 | $0.901 | $0.850 | 534,000 | |
| $0.906 | -0.025 | -2.7% | $0.930 | $0.930 | $0.876 | 990,700 | |
| $0.931 | -0.009 | -1.0% | $0.959 | $1.050 | $0.930 | 1,981,700 | |
| $0.940 | +0.091 | +10.7% | $0.990 | $0.997 | $0.841 | 11,059,000 | |
| $0.849 | -0.021 | -2.4% | $0.846 | $0.884 | $0.841 | 477,800 | |
| $0.870 | -0.013 | -1.5% | $0.899 | $0.944 | $0.860 | 890,300 | |
| $0.883 | -0.011 | -1.2% | $0.906 | $0.940 | $0.853 | 897,600 | |
| $0.894 | +0.022 | +2.5% | $0.883 | $0.912 | $0.824 | 1,403,800 | |
| $0.872 | +0.064 | +7.9% | $0.820 | $0.910 | $0.793 | 1,032,900 | |
| $0.808 | +0.003 | +0.4% | $0.805 | $0.839 | $0.800 | 429,200 | |
| $0.805 | -0.031 | -3.7% | $0.847 | $0.850 | $0.802 | 469,700 | |
| $0.836 | +0.023 | +2.8% | $0.810 | $0.880 | $0.800 | 613,300 | |
| $0.813 | +0.017 | +2.1% | $0.800 | $0.820 | $0.800 | 247,100 | |
| $0.796 | +0.006 | +0.8% | $0.790 | $0.804 | $0.770 | 184,700 | |
| $0.790 | -0.015 | -1.9% | $0.820 | $0.820 | $0.782 | 611,400 | |
| $0.805 | +0.024 | +3.1% | $0.789 | $0.826 | $0.760 | 760,200 | |
| $0.781 | -0.004 | -0.5% | $0.785 | $0.789 | $0.754 | 618,900 | |
| $0.785 | +0.012 | +1.6% | $0.783 | $0.798 | $0.761 | 548,300 | |
| $0.773 | -0.001 | -0.1% | $0.802 | $0.802 | $0.770 | 300,300 | |
| $0.774 | -0.027 | -3.4% | $0.785 | $0.801 | $0.773 | 327,900 | |
| $0.801 | -0.003 | -0.4% | $0.815 | $0.816 | $0.790 | 284,100 | |
| $0.804 | +0.014 | +1.8% | $0.793 | $0.814 | $0.775 | 429,000 | |
| $0.790 | +0.004 | +0.5% | $0.811 | $0.811 | $0.781 | 189,000 | |
| $0.786 | -0.005 | -0.6% | $0.791 | $0.824 | $0.780 | 249,400 | |
| $0.791 | -0.031 | -3.8% | $0.810 | $0.826 | $0.786 | 497,500 | |
| $0.822 | +0.009 | +1.1% | $0.830 | $0.839 | $0.810 | 258,600 | |
| $0.813 | -0.024 | -2.9% | $0.820 | $0.833 | $0.800 | 524,500 | |
| $0.837 | +0.031 | +3.8% | $0.830 | $0.844 | $0.803 | 606,400 | |
| $0.806 | -0.005 | -0.6% | $0.824 | $0.830 | $0.792 | 519,500 | |
| $0.811 | -0.013 | -1.6% | $0.825 | $0.830 | $0.807 | 242,000 | |
| $0.824 | -0.009 | -1.1% | $0.831 | $0.842 | $0.813 | 311,900 | |
| $0.833 | -0.012 | -1.4% | $0.852 | $0.857 | $0.831 | 326,200 | |
| $0.845 | -0.023 | -2.6% | $0.880 | $0.885 | $0.834 | 550,100 | |
| $0.868 | -0.002 | -0.2% | $0.888 | $0.888 | $0.831 | 571,300 | |
| $0.870 | +0.014 | +1.6% | $0.860 | $0.880 | $0.850 | 456,604 | |
| $0.856 | -0.046 | -5.1% | $0.911 | $0.911 | $0.850 | 633,578 | |
| $0.902 | -0.002 | -0.2% | $0.920 | $0.920 | $0.880 | 531,800 | |
| $0.904 | +0.002 | +0.2% | $0.896 | $0.927 | $0.883 | 741,600 |
- Ticker
- NASDAQ:HYPR
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 19, 2026
Hyperfine to Present at the Piper Sandler 38th Annual Healthcare Conference on December 3
Latest earnings call · Nov 9, 2026
Hyperfine (NASDAQ:HYPR) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Nov 9, 2026
Q3 2026 Earnings Presentation
Earnings · 26 slides
Latest news
Hyperfine to Present at the Piper Sandler 38th Annual Healthcare Conference on December 3
Nov 19, 2026
Closed $0.547 (+0.3%) on Nov 20, 2026
Hyperfine, Inc. Reports Third Quarter 2026 Financial Results
Nov 9, 2026
Closed $0.681 (-3.6%) on Nov 10, 2026
Hyperfine to Participate in Jefferies London and BTIG Tech-Enabled Healthcare Conferences
Nov 3, 2026
Closed $0.75 (+8.4%) on Nov 4, 2026
Hyperfine Advances International Swoop System Model 2 Rollout and Highlights the Role of Portable MRI in Brain Health Awareness
Oct 22, 2026
Closed $0.726 (-2.7%) on Oct 22, 2026
Hyperfine Reports Record Preliminary Third Quarter Revenue of Approximately $6.0 Million & Reaffirms Full Year 2026 Revenue Outlook of Approximately $20 to $22 Million
Oct 8, 2026
Closed $0.94 (+10.7%) on Oct 8, 2026
Hyperfine, Inc. to Announce Third Quarter 2026 Financial Results on November 9, 2026
Oct 8, 2026
Closed $0.94 (+10.7%) on Oct 8, 2026
Hyperfine Expands Global Access to Portable Brain MRI Technology Across Key Gulf Cooperation Council Healthcare Markets
Sep 28, 2026
Closed $0.836 (+2.8%) on Sep 28, 2026
Hyperfine Announces Completion of Enrollment in the Contrast PMR Study to Support the Submission to Expand Indications for Use of the Swoop® System with Contrast Agents
Sep 15, 2026
Closed $0.801 (-0.4%) on Sep 15, 2026
Hyperfine, Inc. to Participate in Lake Street Capital Markets 10th Annual Best Ideas Growth Conference
Aug 31, 2026
Closed $0.824 (-1.1%) on Aug 31, 2026
Hyperfine Builds Momentum in Year One of Neurology Office Launch with NEURO PMR Publication and More Than 3,000 Scans
Aug 26, 2026
Closed $0.868 (-0.2%) on Aug 26, 2026
Hyperfine, Inc. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 35 in the last 12 months · 126 in all · newest Nov 19, 2026 · oldest 2021
- Calls
- 20 calls with a replay · 20 with a transcript · latest Nov 9, 2026
- Decks
- 15 decks · latest Nov 9, 2026
Where Hyperfine, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:HYPR · Home listing · This page | NASDAQ | United States | USD |
| BOATS:HYPR | BOATS | United States | USD |
Valuation
EV/sales 1.3× against a median of 2.1×: 4th lowest of 10 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $25.21M USD
- P/E
- Loss
- EV/sales
- 1.3×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 1.6×
- Gross margin
- 52.6%
- Operating margin
- −167.6%
- Net margin
- −156.4%
- Debt to equity
- 0.4×
- Beta vs S&P 500
- 1.67
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Hyperfine, Inc. · NASDAQ:HYPR | US$49.73M | US$25.21M | n/a | 1.3× | n/a | 1.6× | −156.4% | 0.4× | 1.67 |
| Envoy Medical, Inc. · NASDAQ:COCH | US$51.89M | US$38.10M | n/a | 165× | n/a | n/a | n/a | n/a | 1.04 |
| OSTEONIC Co., Ltd. · KRX:226400 | US$50.52M | US$37.57M | 6.7× | 1.0× | 3.8× | 0.9× | 20.0% | 0.1× | n/a |
| Theraclion SA · EURONEXT:ALTHE | US$50.29M | US$49.99M | n/a | 38.4× | n/a | n/a | −479.8% | n/a | n/a |
| Senzime AB · OMXSTO:SEZI | US$49.90M | US$49.14M | n/a | 4.7× | n/a | 2.0× | −92.2% | 0.1× | n/a |
| Modulight Oyj · OMXHEX:MODU | US$48.72M | US$43.29M | n/a | 5.9× | 23.0× | 1.1× | −50.1% | 0.0× | n/a |
| DRTECH Corp. · KRX:214680 | US$48.37M | US$31.72M | n/a | 0.3× | 34.4× | 0.8× | −9.9% | 0.3× | n/a |
| Hironic Co.Ltd · KRX:149980 | US$48.36M | US$32.54M | 14.4× | 1.2× | 6.7× | 0.8× | 12.2% | 0.0× | n/a |
| Venus Medtech (Hangzhou), Inc. Class H · HKEX:2500 | US$48.32M | US$65.50M | n/a | 1.4× | n/a | 0.2× | −132.9% | 0.1× | n/a |
| Medimaging Integrated Solution Inc. · TWSE:6796 | US$48.03M | US$43.05M | 111× | 2.1× | 28.6× | 1.9× | 2.1% | 0.5× | n/a |
| Conexeu Sciences Inc. · NASDAQ:CNXU | US$47.79M | US$45.82M | n/a | n/a | n/a | 8.2× | n/a | 0.0× | 2.08 |
| Median of the others | US$48.55M | US$43.17M | 14.4× | 2.1× | 23.0× | 1.0× | −30.0% | 0.1× | 1.56 |
Forecasts
4 strong buy · Analysts' consensus from EODHD, read Nov 12, 2026. Not 6ix's view and not investment advice.
- Price target
- 2.02 USD · Analysts' mean
- EPS, year to Dec 2026
- -0.32 · 1 analyst
- Revenue, year to Dec 2026
- 20.23M · 3 analysts
Team and board
| Officer | Role |
|---|---|
| Maria Sainz | President and CEO |
| Brett Hale | Chief Administrative Officer and Chief Financial Officer |
| Tom Teisseyre | Chief Operating Officer |
| Leslie Grab | General Counsel |
| Chi Nguyen | Senior Vice President of Office and Community Business |
| Rafael Donnay | Senior Vice President of Hospital Business |
| Rafael O’Halloran | Vice President of Technology |
| Edmond Knopp | Chief Medical Officer |
| Eric Willis | Vice President of International |
| Rob Fasciano | Chief Regulatory and Quality Officer |
| Todd Finch | Vice President of US Sales |
Events
Calls
| Call | When | Status |
|---|---|---|
| Hyperfine (NASDAQ:HYPR) Q3 2026 Earnings Call | Mon, Nov 09, 2026 · 4:30 PM ET | Replay |
| Hyperfine (NASDAQ:HYPR) Q2 2026 Earnings Call | Thu, Aug 06, 2026 · 4:30 PM ET | Replay |
| Hyperfine (NASDAQ:HYPR) Q1 2026 Earnings Call | Tue, May 12, 2026 · 4:30 PM ET | Replay |
| Hyperfine (NASDAQ:HYPR) Q4 2025 Earnings Call | Wed, Mar 18, 2026 · 4:30 PM ET | Replay |
| Hyperfine (NASDAQ:HYPR) Q3 2025 Earnings Call | Thu, Nov 13, 2025 · 4:30 PM ET | Replay |
| Hyperfine (NASDAQ:HYPR) Q2 2025 Earnings Call | Wed, Aug 13, 2025 · 4:30 PM ET | Replay |
| Hyperfine (NASDAQ:HYPR) Q1 2025 Earnings Call | Tue, May 13, 2025 · 4:30 PM ET | Replay |
| Hyperfine (NASDAQ:HYPR) Q4 2024 Earnings Call | Mon, Mar 17, 2025 · 4:30 PM ET | Replay |
| Hyperfine (NASDAQ:HYPR) Q3 2024 Earnings Call | Tue, Nov 12, 2024 · 4:30 PM ET | Replay |
| Hyperfine (NASDAQ:HYPR) Q2 2024 Earnings Call | Thu, Aug 08, 2024 · 4:30 PM ET | Replay |
All 20 calls
| Call | When | Status |
|---|---|---|
| Hyperfine (NASDAQ:HYPR) Q1 2024 Earnings Call | Mon, May 13, 2024 · 4:30 PM ET | Replay |
| Hyperfine (NASDAQ:HYPR) Q4 2023 Earnings Call | Thu, Mar 21, 2024 · 4:30 PM ET | Replay |
| Hyperfine (NASDAQ:HYPR) Q3 2023 Earnings Call | Thu, Nov 09, 2023 · 4:30 PM ET | Replay |
| Hyperfine (NASDAQ:HYPR) Q2 2023 Earnings Call | Mon, Aug 14, 2023 · 4:30 PM ET | Replay |
| Hyperfine (NASDAQ:HYPR) Q1 2023 Earnings Call | Thu, May 11, 2023 · 4:30 PM ET | Replay |
| Hyperfine (NASDAQ:HYPR) Q4 2022 Earnings Call | Tue, Mar 21, 2023 · 4:30 PM ET | Replay |
| Hyperfine (NASDAQ:HYPR) Q3 2022 Earnings Call | Thu, Nov 10, 2022 · 4:30 PM ET | Replay |
| Hyperfine (NASDAQ:HYPR) Q2 2022 Earnings Call | Wed, Aug 10, 2022 · 4:30 PM ET | Replay |
| Hyperfine (NASDAQ:HYPR) Q1 2022 Earnings Call | Wed, May 11, 2022 · 4:30 PM ET | Replay |
| Hyperfine (NASDAQ:HYPR) Q4 2021 Earnings Call | Wed, Mar 23, 2022 · 4:30 PM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 9, 2026 · After close | −3.6% |
| Q2 2026 | Aug 6, 2026 · After close | −2.8% |
| Q1 2026 | May 7, 2026 | −2.3% |
| Q4 2025 | Mar 18, 2026 · After close | −4.7% |
| Q3 2025 | Nov 13, 2025 · After close | +9.5% |
| Q2 2025 | Aug 13, 2025 · After close | +14.2% |
| Q1 2025 | May 13, 2025 · After close | −12.5% |
| Q4 2024 | Mar 17, 2025 | −0.7% |
| Q3 2024 | Nov 12, 2024 · After close | −7.0% |
| Q2 2024 | Aug 8, 2024 · After close | +2.7% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 13, 2024 · After close | +10.1% |
| Q4 2023 | Mar 21, 2024 · After close | −10.6% |
| Q3 2023 | Nov 9, 2023 · After close | −21.4% |
| Q2 2023 | Aug 14, 2023 · After close | −2.1% |
| Q1 2023 | May 11, 2023 · After close | 0.0% |
| Q4 2022 | Mar 21, 2023 · After close | −9.7% |
| Q3 2022 | Nov 10, 2022 · After close | +3.2% |
| Q2 2022 | Aug 10, 2022 · After close | −23.2% |
| Q1 2022 | May 11, 2022 · After close | −4.1% |
| Q4 2021 | Mar 23, 2022 · After close | −6.2% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2026 Earnings Presentation | Earnings | 26 slides | Nov 9, 2026 |
| Investor Presentation (October 2026) | Investor deck | 26 slides | Oct 8, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 21 slides | May 12, 2026 |
| Investor Presentation (January 2026) | Investor deck | 21 slides | Jan 12, 2026 |
| Q3 2025 Earnings Presentation | Earnings | 24 slides | Nov 13, 2025 |
| Investor Presentation (October 2025) | Investor deck | 24 slides | Oct 15, 2025 |
| Investor Presentation (February 2025) | Investor deck | 35 slides | Feb 11, 2025 |
| Investor Presentation (May 2022) | Investor deck | 42 slides | May 11, 2022 |
| Investor Presentation (March 2022) | Investor deck | 41 slides | Mar 9, 2022 |
| Investor Presentation (January 2022) | Investor deck | 32 slides | Jan 10, 2022 |
All 15 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| HealthCor Catalio Acquisition — SPAC Merger (September 2021) | SPAC merger | 50 slides | Sep 27, 2021 |
| HealthCor Catalio Acquisition — SPAC Merger (July 2021) | SPAC merger | 39 slides | Jul 8, 2021 |
| HealthCor Catalio Acquisition — SPAC Merger (July 2021) | SPAC merger | 13 slides | Jul 8, 2021 |
| SPAC Merger (July 2021) | SPAC merger | 52 slides | Jul 8, 2021 |
| SPAC Merger (July 2021) | SPAC merger | 39 slides | July 2021 |
Financings
| Raise | Date |
|---|---|
| Public offering of class A common stock Update: about US$17.5M · US$1.25 a share · Lake Street Capital Markets, LLC Dealers: Lake Street Capital Markets, LLC (lead) Use of proceeds: Working capital and general corporate purposes, including commercial, manufacturing, and research and development activities | Oct 16, 2025 |
| Registered direct offering of registered direct offering Closed: US$6M raised · US$1.33 a share · Warrants at US$1.33 for 60 months · Lake Street Capital Markets Dealers: Lake Street Capital Markets (lead) Use of proceeds: To extend the cash runway, expected to fund planned operations until the end of 2026 | Mar 17, 2025 |
Open Financings · Read by 6ix AI from the company's releases
IPO
Went public as HealthCor Catalio Acquisition Corp., a blank check company (SPAC). Priced at US$10.00 a share on Jan 26, 2021.
- Price
- US$10.00 a share
- Shares offered
- 18,000,000 Class A ordinary shares
- Offering size
- US$180 million
- Underwriters' option
- Up to 2,700,000 more shares
- Listing
- HCAQ on the Nasdaq Capital Market
- Underwriter
- Jefferies
- Shares delivered
- On or about Jan 29, 2021
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Dec 9, 2020 |
| Filed publicly | Jan 11, 2021 |
| Amended twice | Newest Jan 19, 2021 |
| Shares registered with an exchange | Jan 26, 2021 |
| Declared effective by the SEC | Jan 26, 2021 |
| Final prospectus, with the price | Jan 28, 2021 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Jan 28, 2021 |
| CERT · Exchange's certificate of listing | Jan 27, 2021 |
| EFFECT · Notice that a registration is effective | Jan 26, 2021 |
| S-1MEF · Registration of more shares for the same offering | Jan 26, 2021 |
| 8-A12B · Registration of shares for listing on an exchange | Jan 26, 2021 |
| S-1/A · Registration statement, amended | Jan 19, 2021 |
| S-1/A · Registration statement, amended | Jan 11, 2021 |
| S-1 · Registration statement | Jan 11, 2021 |
| DRS · Draft registration statement | Dec 9, 2020 |
Open IPO · From the cover of the final prospectus (424B4) filed Jan 28, 2021
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 13.6M | 12.9M | 11.0M | 6.81M | 1.50M | 294.0K | 0 |
| Cost of revenue | 6.81M | 7.00M | 6.28M | 5.91M | 2.66M | 771.0K | 0 |
| Gross profit | 6.75M | 5.89M | 4.76M | 907.0K | -1.17M | -477.0K | 0 |
| Research and development | 17.5M | 22.5M | 22.5M | 28.2M | 25.8M | 14.6M | 13.4M |
| Selling, general and administrative | 16.3M | 17.5M | 20.3M | 32.4M | 27.5M | 5.92M | 5.81M |
| Operating income | -37.1M | -43.2M | -48.1M | -73.9M | -64.9M | -23.5M | -20.0M |
| Depreciation and amortization | 1.09M | 1.01M | 1.05M | 1.01M | 726.0K | 289.0K | 141.0K |
| EBITDA | -36.0M | -42.2M | -47.1M | -72.9M | -64.1M | -23.2M | -19.8M |
| Interest expense | 710.0K | 18.0K | 70.0K | 630.0K | |||
| Income before tax | -35.6M | -40.7M | -44.2M | -73.2M | -64.9M | -23.4M | -19.4M |
| Income tax | 0 | 0 | 0 | 0 | 0 | -70.0K | -630.0K |
| Net income | -35.6M | -40.7M | -44.2M | -44.2M | -64.9M | -23.4M | -18.8M |
| Earnings per share, basic | -0.43 | -0.56 | -0.62 | -1.04 | -17.57 | -15.38 | -4.06 |
| Earnings per share, diluted | -0.43 | -0.56 | -0.62 | -1.04 | -17.57 | -15.38 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 35.1M | 37.6M | 75.2M | 117.5M | 188.5M | 62.7M | 26.4M |
| Receivables | 5.25M | 5.96M | 3.19M | 2.10M | 553.0K | 174.0K | 683.0K |
| Inventory | 7.09M | 5.83M | 6.58M | 4.62M | 4.31M | 1.72M | 0 |
| Current assets | 50.9M | 53.7M | 88.9M | 128.7M | 197.5M | 68.3M | 28.0M |
| Property, plant and equipment | 2.55M | 3.12M | 3.00M | 3.25M | 3.75M | 1.90M | 489.0K |
| Total assets | 55.3M | 58.9M | 94.2M | 134.1M | 202.5M | 71.5M | 30.6M |
| Accounts payable | 4.05M | 1.61M | 1.21M | 678.0K | 2.25M | 948.0K | 1.19M |
| Current liabilities | 11.7M | 8.73M | 8.77M | 8.80M | 15.7M | 4.12M | 1.79M |
| Long-term debt | 0 | 178.0K | |||||
| Total debt | 0 | 269.0K | 185.0K | 178.0K | |||
| Total liabilities | 14.3M | 9.86M | 9.80M | 10.3M | 16.2M | 4.29M | 1.79M |
| Shareholders' equity | 41.0M | 49.0M | 84.4M | 123.7M | 186.2M | -61.1M | 28.8M |
| Shares outstanding | 94.2M | 72.4M | 71.3M | 70.4M | 70.3M | 25.2M | 4.62M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -27.9M | -38.8M | -41.8M | -72.3M | -47.2M | -21.5M | -18.4M |
| Capital spending | -1.19M | -383.0K | -804.0K | -585.0K | -2.71M | -1.57M | -244.0K |
| Free cash flow | -29.1M | -39.1M | -42.6M | -72.9M | -49.9M | -23.1M | -18.6M |
| Cash from investing | -1.19M | -383.0K | -804.0K | -585.0K | -2.71M | -1.57M | -244.0K |
| Cash from financing | 27.5M | 1.02M | 174.0K | 7.00K | 176.8M | 60.9M | 4.74M |
| Share buybacks | 7.00K | 35.5M | |||||
| Change in cash | -1.63M | -38.1M | -42.4M | -72.9M | 126.9M | 37.8M | -13.9M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| EFFECT · Notice that a registration is effective | Nov 20, 2026 | Other filings | SEC |
| S-3 · Registration statement | Nov 9, 2026 | Offer document | SEC |
| 10-Q · Quarterly report | Nov 9, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 9, 2026 | Results | SEC |
| 8-K · Current report | Oct 8, 2026 | Results | SEC |
| 8-K · Current report | Sep 18, 2026 | Current report | SEC |
| 4 · Change in ownership | Aug 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 25, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 6, 2026 | Quarterly report | SEC |
| 8-K · Current report | Aug 6, 2026 | Results | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| SCHEDULE 13G · Big-stake notice | Jul 28, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Jun 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2026 | Insider trade | SEC |
| EFFECT · Notice that a registration is effective | May 22, 2026 | Other filings | SEC |
| 8-K · Current report | May 21, 2026 | Meeting outcome | SEC |
| CORRESP · Letter to the SEC | May 19, 2026 | Other filings | SEC |
| UPLOAD · Letter from the SEC | May 18, 2026 | Other filings | SEC |
| S-3 · Registration statement | May 12, 2026 | Offer document | SEC |
| 10-Q · Quarterly report | May 12, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 12, 2026 | Results | SEC |
| ARS · Annual report to shareholders | Apr 8, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 8, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 8, 2026 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 25, 2026 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Mar 18, 2026 | Offer document | SEC |
| 10-K · Annual report | Mar 18, 2026 | Annual report | SEC |
| 8-K · Current report | Mar 18, 2026 | Material contract | SEC |
| 8-K · Current report | Mar 18, 2026 | Results | SEC |
| 4 · Change in ownership | Feb 17, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jan 30, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Jan 12, 2026 | Results | SEC |
| 8-K · Current report | Dec 29, 2025 | Material contract | SEC |
| 424B5 · Prospectus | Dec 29, 2025 | Offer document | SEC |
| 4 · Change in ownership | Nov 19, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 13, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 13, 2025 | Results | SEC |
| 424B5 · Prospectus | Oct 16, 2025 | Offer document | SEC |
| 8-K · Current report | Oct 16, 2025 | Material contract | SEC |
| 424B5 · Prospectus | Oct 15, 2025 | Offer document | SEC |
| 8-K · Current report | Oct 15, 2025 | Results | SEC |
| 4 · Change in ownership | Aug 18, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 13, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 13, 2025 | Results | SEC |
| 8-K · Current report | Aug 6, 2025 | Current report | SEC |
| 4 · Change in ownership | Jun 6, 2025 | Insider trade | SEC |
| 8-K · Current report | May 23, 2025 | Management or board change | SEC |
| 4 · Change in ownership | May 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2025 | Insider trade | SEC |
| 8-K · Current report | May 19, 2025 | Meeting outcome | SEC |
| 4 · Change in ownership | May 16, 2025 | Insider trade | SEC |
| 424B5 · Prospectus | May 13, 2025 | Offer document | SEC |
| 10-Q · Quarterly report | May 13, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 13, 2025 | Results | SEC |
| 8-K · Current report | May 2, 2025 | Current report | SEC |
| ARS · Annual report to shareholders | Apr 7, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 7, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 7, 2025 | Meeting notice | SEC |
| S-8 · Registration statement for employee plans | Mar 17, 2025 | Offer document | SEC |
| 10-K · Annual report | Mar 17, 2025 | Annual report | SEC |
| 8-K · Current report | Mar 17, 2025 | Results | SEC |
| 4/A · Change in ownership, amended | Feb 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2025 | Insider trade | SEC |
| 8-K · Current report | Feb 11, 2025 | Material contract | SEC |
| 424B5 · Prospectus | Feb 11, 2025 | Offer document | SEC |
| 8-K · Current report | Feb 11, 2025 | Results | SEC |
| 8-K · Current report | Jan 29, 2025 | Current report | SEC |
| 4 · Change in ownership | Nov 18, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 12, 2024 | Quarterly report | SEC |
| 8-K · Current report | Nov 12, 2024 | Results | SEC |
| 4 · Change in ownership | Aug 16, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 9, 2024 | Quarterly report | SEC |
| 8-K · Current report | Aug 8, 2024 | Results | SEC |
| 8-K · Current report | Jul 24, 2024 | Current report | SEC |
| 4 · Change in ownership | Jun 12, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2024 | Insider trade | SEC |
| 8-K · Current report | Jun 12, 2024 | Meeting outcome | SEC |
| 8-K · Current report | May 31, 2024 | Current report | SEC |
| 4 · Change in ownership | May 16, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | May 14, 2024 | Quarterly report | SEC |
| 8-K · Current report | May 13, 2024 | Results | SEC |
| ARS · Annual report to shareholders | Apr 26, 2024 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 26, 2024 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 26, 2024 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Apr 16, 2024 | Meeting notice | SEC |
| 4 · Change in ownership | Mar 28, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 28, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 28, 2024 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Mar 22, 2024 | Offer document | SEC |
| 424B5 · Prospectus | Mar 22, 2024 | Offer document | SEC |
| 10-K · Annual report | Mar 22, 2024 | Annual report | SEC |
| 8-K · Current report | Mar 21, 2024 | Results | SEC |
| 4 · Change in ownership | Feb 16, 2024 | Insider trade | SEC |
| SC 13G · Big-stake notice | Feb 13, 2024 | Big-stake notice | SEC |
| EFFECT · Notice that a registration is effective | Nov 24, 2023 | Other filings | SEC |
| 3/A · Initial statement of ownership, amended | Nov 20, 2023 | Insider trade | SEC |
| CORRESP · Letter to the SEC | Nov 20, 2023 | Other filings | SEC |
| 4 · Change in ownership | Nov 17, 2023 | Insider trade | SEC |
| UPLOAD · Letter from the SEC | Nov 17, 2023 | Other filings | SEC |
| 8-K · Current report | Nov 9, 2023 | Material contract | SEC |
| S-3 · Registration statement | Nov 9, 2023 | Offer document | SEC |
| 10-Q · Quarterly report | Nov 9, 2023 | Quarterly report | SEC |
| 8-K · Current report | Nov 9, 2023 | Results | SEC |
| 8-K · Current report | Oct 3, 2023 | Management or board change | SEC |
| 4 · Change in ownership | Aug 17, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Aug 17, 2023 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 14, 2023 | Quarterly report | SEC |
| 8-K · Current report | Aug 14, 2023 | Results | SEC |
| 3/A · Initial statement of ownership, amended | Jul 24, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jul 24, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 24, 2023 | Insider trade | SEC |
| 8-K · Current report | Jul 18, 2023 | Management or board change | SEC |
| 4/A · Change in ownership, amended | Jul 3, 2023 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Jul 3, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2023 | Insider trade | SEC |
| 8-K · Current report | Jun 12, 2023 | Meeting outcome | SEC |
| 4 · Change in ownership | May 25, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 16, 2023 | Insider trade | SEC |
| 10-Q · Quarterly report | May 11, 2023 | Quarterly report | SEC |
| 8-K · Current report | May 11, 2023 | Results | SEC |
| ARS · Annual report to shareholders | Apr 24, 2023 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 24, 2023 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 24, 2023 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Apr 12, 2023 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 10, 2023 | Insider trade | SEC |
| 8-K · Current report | Mar 29, 2023 | Current report | SEC |
| S-8 · Registration statement for employee plans | Mar 22, 2023 | Offer document | SEC |
| 10-K · Annual report | Mar 22, 2023 | Annual report | SEC |
| 8-K/A · Current report, amended | Mar 22, 2023 | Results | SEC |
| 8-K · Current report | Mar 21, 2023 | Results | SEC |
| 8-K · Current report | Mar 10, 2023 | Current report | SEC |
| 8-K · Current report | Feb 21, 2023 | Current report | SEC |
| 4 · Change in ownership | Feb 17, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Feb 17, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Feb 15, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | Feb 15, 2023 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 14, 2023 | Big-stake notice | SEC |
| 8-K · Current report | Feb 8, 2023 | Management or board change | SEC |
| EFFECT · Notice that a registration is effective | Jan 31, 2023 | Other filings | SEC |
| 424B3 · Prospectus | Jan 30, 2023 | Offer document | SEC |
| POS AM · Amendment to an effective registration | Jan 24, 2023 | Offer document | SEC |
| 4 · Change in ownership | Dec 20, 2022 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Dec 20, 2022 | Big-stake notice | SEC |
| 424B3 · Prospectus | Dec 20, 2022 | Offer document | SEC |
| 4 · Change in ownership | Dec 14, 2022 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Dec 12, 2022 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Dec 12, 2022 | Insider trade | SEC |
| 424B3 · Prospectus | Dec 12, 2022 | Offer document | SEC |
| 8-K · Current report | Dec 12, 2022 | Current report | SEC |
| 4 · Change in ownership | Dec 12, 2022 | Insider trade | SEC |
| 424B3 · Prospectus | Dec 9, 2022 | Offer document | SEC |
| 8-K · Current report | Dec 9, 2022 | Management or board change | SEC |
| 8-K · Current report | Dec 9, 2022 | Current report | SEC |
| 4 · Change in ownership | Dec 8, 2022 | Insider trade | SEC |
| 424B3 · Prospectus | Dec 8, 2022 | Offer document | SEC |
| 8-K · Current report | Dec 8, 2022 | Management or board change | SEC |
| SC 13D/A · Big-stake notice, amended | Dec 6, 2022 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 30, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Nov 29, 2022 | Insider trade | SEC |
| 424B3 · Prospectus | Nov 23, 2022 | Offer document | SEC |
| 8-K · Current report | Nov 23, 2022 | Management or board change | SEC |
| 4 · Change in ownership | Nov 16, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Nov 16, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Nov 16, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Nov 15, 2022 | Insider trade | SEC |
| 424B3 · Prospectus | Nov 15, 2022 | Offer document | SEC |
| 8-K/A · Current report, amended | Nov 15, 2022 | Current report | SEC |
| 4 · Change in ownership | Nov 14, 2022 | Insider trade | SEC |
| 8-K · Current report | Nov 14, 2022 | Current report | SEC |
| 424B3 · Prospectus | Nov 14, 2022 | Offer document | SEC |
| 424B3 · Prospectus | Nov 10, 2022 | Offer document | SEC |
| 10-Q · Quarterly report | Nov 10, 2022 | Quarterly report | SEC |
| 8-K · Current report | Nov 10, 2022 | Results | SEC |
| 4 · Change in ownership | Nov 1, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Nov 1, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Nov 1, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Nov 1, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Nov 1, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Nov 1, 2022 | Insider trade | SEC |
| DEF 14C | Oct 6, 2022 | Meeting notice | SEC |
| 424B3 · Prospectus | Oct 6, 2022 | Offer document | SEC |
| 8-K · Current report | Oct 6, 2022 | Management or board change | SEC |
This page holds 200 of 371 filings. Open Filings
Cap table
Built by 6ix from Hyperfine, Inc.’s releases · as of Mar 17, 2025
- Common shares
- 90,993,381
- Fully diluted
- 90,993,381
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 90,993,381 |
Warrants and options
| Lot |
|---|
| Warrants · US$1.33 · expire about Feb 2030 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 90,993,381 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Maria Sainz Other companies: Pulse Biosciences, Inc (Board Member · Since at least Jan 8, 2026); ATRION Corporation (Director · Aug 30, 2021 – May 24, 2022 · Past); Shockwave Medical Inc (Director · Jul 16, 2020 – May 31, 2024 · Past); Avanos Medical, Inc. (Director · Jan 2, 2019 – Jan 3, 2022 · Past); IRIDEX Corporation (Director · Apr 13, 2018 – Jul 23, 2019 · Past); Halyard Health Inc (Director · Feb 2, 2015 – May 3, 2018 · Past); ClearPoint Neuro Inc. (Director · Jan 1, 2014 – Mar 30, 2018 · Past); The Spectranetics Corp (Director · Nov 1, 2010 – Aug 9, 2017 · Past); Orthofix Medical Inc. (Director · Jun 19, 2008 – Jun 8, 2020 · Past); Guidant Corp (President, Cardiac Surgery · Mar 31, 2006 – Apr 21, 2006 · Past) | President and CEO · Since at least Dec 22, 2021 |
| Scott Huennekens Other companies: NeuroPace, Inc. (Director · Since at least Jan 6, 2025); QuidelOrtho Corporation (Director · Since at least Dec 6, 2024); Envista Holdings Corporation (Director · Since at least Sep 20, 2019); Acutus Medical Inc. (Director · Aug 5, 2020 – Jun 15, 2023 · Past); NuVasive Inc (Director · Oct 1, 2018 – Sep 1, 2023 · Past); EndoChoice Holdings Inc (Director · Jun 5, 2015 – Nov 22, 2016 · Past); Bellerophon Therapeutics Inc (Director · May 12, 2015 – May 12, 2015 · Past); Volcano Corp (President & Chief Executive Of, Director · Jun 14, 2006 – Feb 17, 2015 · Past) | Director · Dec 22, 2021 – Jun 12, 2024 · Past |
| Taylor Harris Other companies: Establishment Labs Holdings Inc. (Board Member · Since at least Jun 24, 2026); PROCEPT BioRobotics Corporation (CHAIR OF THE AUDIT COMMITTEE · Since at least Sep 14, 2021); Cutera Inc (Chief Executive Officer, Director · May 19, 2023 – Feb 7, 2025 · Past); MyoKardia Inc (Chief Financial Officer · Apr 4, 2018 – Nov 17, 2020 · Past); Zeltiq Aesthetics Inc (SVP & Chief Financial Officer · Apr 18, 2016 – Apr 28, 2017 · Past) | Director · Jan 26, 2021 – Jan 26, 2021 · Past |
| Daniel J. Wolterman Other companies: Globus Medical, Inc. (Director · Since at least Sep 1, 2023); Invuity Inc (Director · Sep 5, 2017 – Oct 23, 2018 · Past); NuVasive Inc (Director · Jul 2, 2015 – Sep 1, 2023 · Past); Volcano Corp (Director · Sep 10, 2013 – Feb 17, 2015 · Past) | Director · Since at least Dec 22, 2021 |
| John T Dahldorf Other companies: Adagio Medical Holdings, Inc (Chief Financial Officer · Jul 31, 2024 – Jul 31, 2024 · Past); Volcano Corp (CFO · Jun 14, 2006 – Feb 17, 2015 · Past) | Director · Since at least Dec 22, 2021 |
| Jonathan Rothberg Other companies: Quantum-Si Incorporated (Director · Since at least Jun 10, 2021); Butterfly Network, Inc. (Director · Since at least Feb 12, 2021) | Director · Since at least Dec 22, 2021 |
| Ruth Fattori Other companies: Quantum-Si Incorporated (Director · Since at least Jun 10, 2021); PepsiCo, Inc. (EVP, HR & Chief HR Officer · Oct 1, 2017 – Mar 1, 2018 · Past) | Director · Since at least Dec 22, 2021 |
| Joseph Patrick Healey Other companies: CareView Communications, Inc. (Director · Sep 30, 2011 – May 24, 2023 · Past) | Director · Jan 26, 2021 – Jan 26, 2021 · Past |
| Avi Daniel Horev | Director · Jan 26, 2021 – Jan 26, 2021 · Past |
| Brett Hale | CFO and CAO · Since at least Mar 31, 2026 |
All 27 people
| Person | Seat |
|---|---|
| Chi Nguyen | Senior Vice President of Office and Community Business · Since at least Aug 26, 2026 |
| Christopher Lee Wolfgang | Director · Jan 26, 2021 – Jan 26, 2021 · Past |
| David D Scott | President and CEO, Director · Dec 22, 2021 – Apr 26, 2022 · Past |
| Edmond Knopp | Chief Medical Officer · Since at least Jul 30, 2026 |
| Eric Willis | Vice President of International · Since at least Oct 22, 2026 |
| George C Petrocheilos | President · Jan 26, 2021 – Jan 26, 2021 · Past |
| Kenan Kent Turnacioglu | Director · Jan 26, 2021 – Jan 26, 2021 · Past |
| Leslie Grab | General Counsel · Since at least Nov 5, 2026 |
| Mark A Hughes | Chief Operating Officer · Dec 22, 2021 – Feb 9, 2022 · Past |
| Michael Neil Weinstein | Director · Jan 26, 2021 – Jan 26, 2021 · Past |
| Neela Paykel | Gen Counsel & Corp Secretary · Dec 22, 2021 – Nov 15, 2022 · Past |
| Rafael Donnay | Senior Vice President of Hospital Business · Since at least Jan 6, 2026 |
| Rafael O’Halloran | Vice President of Technology · Since at least Jun 11, 2025 |
| Rob Fasciano | Chief Regulatory and Quality Officer · Since at least Jun 11, 2025 |
| Thomas Teisseyre | Chief Operating Officer · Since at least Jul 24, 2023 |
| Todd Finch | Vice President of US Sales · Since at least Nov 5, 2026 |
| Tom Teisseyre | Chief Operating Officer · Since at least Aug 20, 2026 |
Log in to ask 6ix AI your own questions about Hyperfine, Inc.